CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
June 2020—PerkinElmer announced that the FDA has provided emergency use authorization for Euroimmun’s Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high-complexity tests under CLIA can use this ELISA for the detection of antibodies of the immunoglobulin class G.
The test has 99 percent specificity and 100 percent sensitivity after 21 days following the onset of symptoms.
Pages: 1 2